导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -21.97% | 4702/4982 |
| 近一周 | -3.38% | 4140/5419 |
| 近一月 | -3.52% | 2068/5423 |
| 近一季 | -9.66% | 2866/5358 |
| 近半年 | -27.10% | 4988/5131 |
| 近一年 | -13.45% | 3844/4733 |
| 近两年 | 59.33% | 1894/4208 |
| 近三年 | 11.68% | 2590/3661 |
| 成立以来 | 197.02% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-6.62% 4177/5130 |
-14.14% 4841/5464 |
- - |
- - |
| 2025 | 45.09% 1097/5130 |
12.97% 377/4624 |
-1.72% 3809/4802 |
31.90% 1421/4970 |
-0.93% 2269/5130 |
| 2024 | -1.50% 2849/4618 |
-11.42% 3710/4340 |
-11.28% 4100/4442 |
15.40% 810/4550 |
8.62% 341/4618 |
| 2023 | 12.42% 57/4216 |
24.03% 20/3759 |
-1.01% 935/3909 |
-6.47% 1704/4055 |
-2.11% 967/4209 |
| 2022 | -15.44% 625/3578 |
-18.43% 1587/2804 |
6.71% 1657/3205 |
-12.34% 1649/3430 |
10.83% 171/3570 |
| 2021 | 18.92% 360/2717 |
-12.54% 1559/1745 |
5.66% 1337/2232 |
11.03% 183/2560 |
15.91% 22/2708 |
| 2020 | 52.85% 568/1596 |
-4.14% 675/1036 |
11.68% 948/1256 |
19.94% 110/1472 |
19.03% 355/1690 |
| 2019 | 33.76% 508/926 |
22.21% 1203/3053 |
-6.00% 2686/3201 |
5.53% 459/939 |
10.33% 326/1014 |
| 2018 | -20.29% 168/668 |
- - |
-5.08% 1730/2983 |
-1.61% 1184/2970 |
-12.55% 2445/2975 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商品质成长混合C | 1.0027 | 54.69% |
| 招商创新增长混合A | 1.0759 | 54.25% |
| 招商创新增长混合C | 1.0235 | 53.96% |
| 华泰柏瑞医疗健康A | 2.6422 | 49.29% |
| 华泰柏瑞医疗健康C | 2.5804 | 49.15% |
| 招商品质成长混合A | 1.0435 | 49.15% |
| 大摩优悦安和混合A | 0.8994 | 47.23% |
| 大摩优悦安和混合C | 0.8828 | 47.08% |
| 中信建投医药健康A | 0.7950 | 39.62% |
| 大摩健康产业混合A | 1.9440 | 32.70% |
| 汇丰晋信珠三角区域发展混合 VS. 长安宏观策略混合A(740001) |